MedPath

圣嘉(滨海)生物医药科技有限公司

Ownership
-
Established
2021-12-10
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Cobamamide Capsules

Product Name
腺苷钴胺胶囊
Approval Number
国药准字H20253590
Approval Date
Mar 11, 2025
NMPA

Macrogol Sodium Potassium Powder

Product Name
聚乙二醇钠钾散
Approval Number
国药准字H20253326
Approval Date
Jan 24, 2025
NMPA

Pranoprofen Eye Drops

Product Name
普拉洛芬滴眼液
Approval Number
国药准字H20249494
Approval Date
Dec 1, 2024
NMPA

Dopamine Hydrochloride Injection

Product Name
盐酸多巴胺注射液
Approval Number
国药准字H20249013
Approval Date
Oct 9, 2024
NMPA

Dopamine Hydrochloride Injection

Product Name
盐酸多巴胺注射液
Approval Number
国药准字H20249014
Approval Date
Oct 9, 2024
NMPA

Omeprazole Enteric-coated Capsules

Product Name
奥美拉唑肠溶胶囊
Approval Number
国药准字H20123057
Approval Date
Feb 16, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.